SUE WANG is an associate in Sidley’s San Francisco office and is a member of the IP Litigation practice. Sue focuses on patent litigation in the life sciences, with particular emphasis on biologics and biotechnology. She has represented clients in all stages of litigation, including arguing claim construction and dispositive motions in federal court. Sue also counsels clients regarding intellectual property matters outside of the courtroom, including patent due diligence and pre-litigation strategic planning.
Recent representative matters include:
- Representing biopharmaceutical company in the District of New Jersey in patent litigation involving biosimilars to the company’s blockbuster biologic, including securing a ruling upholding patent validity following a two-week bench trial.
- Representing pharmaceutical company in multiple patent suits in the District of Delaware involving Factor VIII products, including obtaining a jury victory on the patent owner’s behalf that resulted in a damages award of over $150 million.
- Representing software developer in the Northern District of California in declaratory judgment action against non-practicing entity.
- Represented biopharmaceutical company in first-of-its-kind declaratory judgment patent litigation under the Biologics Price Competition and Innovation Act, successfully securing dismissal for lack of an Article III case or controversy.
Sue also maintains an active pro bono practice, representing individual and institutional clients on immigration-related issues such as asylum, and challenges to detention and enforcement policy.
Sue earned her J.D. from Stanford Law School in 2012, where she was a member of the board of the Stanford Technology Law Review. She received her B.A., with general honors, in biological sciences and political science from the University of Chicago.